MedTrace Logo

Expiratory Flow Accelerator (Efa) vs Efa + High Flow in Chronic COPD and Bronchiectasis

NCT06017739 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-02-06

No results posted yet for this study

Summary

The aim of the study is to compare the efficacy of using EFA technology versus the combination of EFA + high flow in hypersecretory patients COPD and bronchiectasis

Conditions

  • Copd
  • Bronchiectasis Adult

Interventions

DEVICE

Bronchial Clearance A

EFA technology: the patient has to breathe at tidal volume by a mouthpiece at level 5 for half an hour twice a day.

DEVICE

Bronchial Clearance B

High Flow Technology: patient has to wear nasal cannula and breathe his nose for one hour twice a day. After he has to use EFA technology level 5 for half an hour twice a day.

Sponsors & Collaborators

  • Azienda Socio Sanitaria Territoriale della Valle Olona

    lead OTHER

Principal Investigators

  • Marianna Messina · ASST Valle Olona

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-09
Primary Completion
2024-07-18
Completion
2025-01-18

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06017739 on ClinicalTrials.gov